Elisa Garbayo

2.8k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Elisa Garbayo is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Elisa Garbayo has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Biomaterials and 18 papers in Surgery. Recurrent topics in Elisa Garbayo's work include Tissue Engineering and Regenerative Medicine (17 papers), Electrospun Nanofibers in Biomedical Applications (16 papers) and Nerve injury and regeneration (13 papers). Elisa Garbayo is often cited by papers focused on Tissue Engineering and Regenerative Medicine (17 papers), Electrospun Nanofibers in Biomedical Applications (16 papers) and Nerve injury and regeneration (13 papers). Elisa Garbayo collaborates with scholars based in Spain, France and United States. Elisa Garbayo's co-authors include María J. Blanco‐Prieto, Felipe Prósper, Simon Pascual‐Gil, Eduardo Ansorena, Laura Saludas, Claudia N. Montero‐Menei, Teresa Simón‐Yarza, José L. Lanciego, Gloria Abizanda and Paul C. Schiller and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Elisa Garbayo

51 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid nanoparticles for siRNA delivery in cancer treatment

2023 105 citations Elisa Garbayo, Simon Pascual‐Gil et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Garbayo Spain	28	790	787	575	515	438	52	2.1k
Yongzhe Che China	25	933 1.2×	442 0.6×	473 0.8×	316 0.6×	252 0.6×	52	2.2k
Zhenbing Chen China	26	1.0k 1.3×	617 0.8×	303 0.5×	492 1.0×	180 0.4×	80	2.7k
Yuan Zhu China	36	1.5k 2.0×	269 0.3×	322 0.6×	468 0.9×	394 0.9×	83	4.0k
Bürkhard Schlosshauer Germany	34	1.1k 1.4×	589 0.7×	599 1.0×	498 1.0×	1.6k 3.7×	112	3.2k
Pietro Veglianese Italy	29	827 1.0×	486 0.6×	253 0.4×	363 0.7×	939 2.1×	56	2.8k
Fang Zhang China	28	625 0.8×	496 0.6×	190 0.3×	821 1.6×	352 0.8×	62	2.2k
Michael J. Cooke Canada	24	881 1.1×	411 0.5×	357 0.6×	461 0.9×	580 1.3×	36	2.1k
Karolina Chwalek Germany	24	838 1.1×	450 0.6×	433 0.8×	717 1.4×	286 0.7×	33	2.4k
James B. Phillips United Kingdom	34	714 0.9×	912 1.2×	814 1.4×	1.0k 2.0×	1.6k 3.6×	132	3.3k
Jiasong Guo China	27	768 1.0×	465 0.6×	310 0.5×	400 0.8×	1.1k 2.4×	71	2.5k

Countries citing papers authored by Elisa Garbayo

Since Specialization

Citations

This map shows the geographic impact of Elisa Garbayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Garbayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Garbayo more than expected).

Fields of papers citing papers by Elisa Garbayo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Garbayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Garbayo. The network helps show where Elisa Garbayo may publish in the future.

Co-authorship network of co-authors of Elisa Garbayo

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Garbayo. A scholar is included among the top collaborators of Elisa Garbayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Garbayo. Elisa Garbayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martínez-Ohárriz, María Cristina, Purificación Ripalda‐Cemboráin, Gloria Abizanda, et al.. (2025). 3D-printed polycaprolactone scaffolds functionalized with poly(lactic-co-glycolic) acid microparticles enhance bone regeneration through tunable drug release. Acta Biomaterialia. 198. 219–233. 4 indexed citations

Santamaría, Enrique, et al.. (2025). Targeting neuroinflammation in Parkinson's disease: Immunomodulatory effects of a hyaluronic acid-based nanoreinforced hydrogel loaded with GDNF and mesenchymal stem cells. European Journal of Pharmaceutical Sciences. 219. 107368–107368. 1 indexed citations

Saludas, Laura, Elisa Garbayo, Gloria Abizanda, et al.. (2025). Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insights. Journal of Controlled Release. 388(Pt 2). 114369–114369.

Simón‐Yarza, Teresa, et al.. (2024). Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics. Advanced Drug Delivery Reviews. 208. 115302–115302. 13 indexed citations

Garbayo, Elisa, Carlos Rodríguez‐Nogales, Xabier Agirre, et al.. (2024). RNA-loaded nanoparticles for the treatment of hematological cancers. Advanced Drug Delivery Reviews. 214. 115448–115448. 7 indexed citations

Garbayo, Elisa, et al.. (2023). Cardiac tissue engineering for myocardial infarction treatment. European Journal of Pharmaceutical Sciences. 185. 106439–106439. 26 indexed citations

Couvreur, Patrick, Sinda Lepêtre‐Mouelhi, Elisa Garbayo, & María J. Blanco‐Prieto. (2023). Self-assembled lipid–prodrug nanoparticles. Nature Reviews Bioengineering. 1(10). 749–768. 36 indexed citations

Plano, Daniel, Jacobo Paredes, Javier Aldazabal, et al.. (2022). Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering. Biomacromolecules. 23(11). 4629–4644. 17 indexed citations

Luquín, M. R., et al.. (2022). Hydrogels for brain repair: application to Parkinson’s disease. Expert Opinion on Drug Delivery. 19(11). 1521–1537. 8 indexed citations

10.

Saludas, Laura, Cláudia C. Oliveira, Carmen Roncal, et al.. (2021). Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials. 11(3). 570–570. 34 indexed citations

11.

Smerdou, Cristian, et al.. (2021). Optimization of a GDNF production method based on Semliki Forest virus vector. European Journal of Pharmaceutical Sciences. 159. 105726–105726. 3 indexed citations

12.

Garbayo, Elisa, Adrián Ruiz‐Villalba, Silvia C. Hernández, et al.. (2021). Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction. Acta Biomaterialia. 126. 394–407. 14 indexed citations

13.

Garbayo, Elisa, Simon Pascual‐Gil, Carlos Rodríguez‐Nogales, et al.. (2020). Nanomedicine and drug delivery systems in cancer and regenerative medicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(5). e1637–e1637. 96 indexed citations

14.

Saludas, Laura, Elisa Garbayo, Beatriz Pelacho, et al.. (2019). Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair. Journal of Pharmacology and Experimental Therapeutics. 370(3). 761–771. 22 indexed citations

15.

Saludas, Laura, et al.. (2018). Micro- and nanotechnology approaches to improve Parkinson's disease therapy. Journal of Controlled Release. 295. 201–213. 58 indexed citations

16.

Saludas, Laura, et al.. (2018). Heart tissue repair and cardioprotection using drug delivery systems. Maturitas. 110. 1–9. 31 indexed citations

17.

Saludas, Laura, Simon Pascual‐Gil, Teresa Simón‐Yarza, et al.. (2017). Transplantation of adipose-derived stem cells combined with neuregulin-microparticles promotes efficient cardiac repair in a rat myocardial infarction model. Journal of Controlled Release. 249. 23–31. 41 indexed citations

18.

Garbayo, Elisa, Eduardo Ansorena, Hugo Lana, et al.. (2016). Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys. Biomaterials. 110. 11–23. 53 indexed citations

19.

Formiga, Fábio Rocha, Beatriz Pelacho, Elisa Garbayo, et al.. (2013). Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. Journal of Controlled Release. 173. 132–139. 86 indexed citations

20.

Garbayo, Elisa, Claudia N. Montero‐Menei, Eduardo Ansorena, et al.. (2008). Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease. Journal of Controlled Release. 135(2). 119–126. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact